Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSND.L Regulatory News (SND)

  • There is currently no data for SND

Exercise of Options

7 Jun 2018 07:00

RNS Number : 6116Q
Sanderson Group PLC
07 June 2018
 

FOR IMMEDIATE RELEASE 7 JUNE 2018

 

 

SANDERSON GROUP PLC

Exercise of Options

 

Sanderson Group plc ('Sanderson' or 'the Group'), the software and IT services business specialising in digital retail technology and enterprise software for businesses operating in the manufacturing, wholesale distribution and logistics sectors, announces that Mr Ian Newcombe, Group Chief Executive, exercised options over 66,250 ordinary shares on 6 June 2018.

The exercised options include 31,250 with an exercise price of 30 pence and a further 35,000 with an exercise price of 27.5 pence, both tranches of options were awarded under the Sanderson Group Company Share Option Plan. Following the option exercise, Mr Newcombe is interested in 178,750 ordinary shares representing 0.30% of the issued share capital of the Group. Application has been made for the new shares to be admitted to AIM and admission is expected to take place on 12 June 2018. Mr Newcombe intends to hold the shares as part of his longer term investment and commitment to Sanderson.

The new ordinary shares pursuant to the exercise of options will rank pari passu with the existing Sanderson ordinary shares. Following allotment of the new ordinary shares, Sanderson will have in issue 59,972,484 ordinary shares of 10p each. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of Sanderson, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

 

Enquiries:

Sanderson Group plc

0333 123 1400

Christopher Winn, Chairman

 

Ian Newcombe, Chief Executive

 

Richard Mogg, Finance Director

 

 

 

N+1 Singer (Nominated Adviser and Broker)

020 7496 3000

Mark Taylor

James White

 

 

 

Walbrook PR LimitedPaul Vann

0117 985 8989

or 07768 807631

 

 

 

 

1

Details of PDMR/person closely associated with them ("PCA")

(a)

Name

Ian Newcombe

(b)

Position / status

Chief Executive Officer

(c)

Initial notification / amendment

Initial notification

2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument

Exercise of Options over 66,250 ordinary shares of 10p each

 

Legal Entity Identifier

213800I78F2ZHZH2T148

(b)

Nature of the transaction

Exercise of options

(c)

Price(s) andvolume(s)

Exercise price(s)

Volume(s)

 

30p

31,250

 

27.5p

35,000

 

 

(d)

Aggregated information

Aggregated volume Price

n/a

(e)

Date of the transaction

6 June 2018

(f)

Place of the transaction

Outside of a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEEASKXEAXPEEF
Date   Source Headline
21st Aug 20247:00 amRNSCancellation - Sondrel (Holdings) plc
12th Aug 20241:54 pmRNSResult of GM, Cancellation and Re-registration
22nd Jul 20247:00 amRNSProposed cancellation of Admission, Notice of GM
18th Jul 20248:09 amRNSFinal Results and Posting of Annual Report-Replace
18th Jul 20247:30 amRNSRestoration - Sondrel (Holdings) plc
18th Jul 20247:01 amRNSChief Financial Officer Succession
18th Jul 20247:00 amRNSFinal Results and Posting of Annual Report
16th Jul 20247:00 amRNSNotice of Results
1st Jul 20247:30 amRNSSuspension - Sondrel (Holdings) plc
27th Jun 20245:32 pmRNSResult of AGM
24th Jun 20244:26 pmRNSSuspension of Trading on AIM
18th Jun 20247:00 amRNSDirectorate Changes
12th Jun 202412:45 pmRNSUpdate re Subscription and Loan Conversion
10th Jun 202410:40 amRNSReceipt of NSIA Approval
30th May 20241:52 pmRNSResult of General Meeting
29th May 20246:07 pmRNSNotice of AGM
29th May 20247:00 amRNSRegulatory Condition to Conditional Subscription
22nd May 20247:00 amRNSChief Executive Officer Succession
14th May 20247:00 amRNSSubscription and Posting of Circular
29th Apr 20242:35 pmRNSPDMR Dealing
29th Apr 20247:00 amRNSSuccessful Milestone Completion
22nd Apr 20244:45 pmRNSPDMR Dealings
10th Apr 20245:26 pmRNSNotification of Major Holdings
2nd Apr 20249:39 amRNSNotification of Major Holdings
28th Mar 20241:08 pmRNSFurther CLN and Amended Exclusivity Agreement
27th Mar 20244:55 pmRNSUpdated Supply Arrangements
25th Mar 20243:46 pmRNSResult of General Meeting
25th Mar 20247:00 amRNSFurther re Material ASIC contract
11th Mar 20247:00 amRNSPosting of Circular and Notice of General Meeting
6th Mar 20247:00 amRNSConvertible Loan Note and Exclusivity Agreement
1st Mar 20247:00 amRNSFurther re Corporate Update
27th Feb 202412:52 pmRNSReplacement: Notification of Major Holdings
27th Feb 20248:33 amRNSNotification of Major Holdings
27th Feb 20247:00 amRNSNew Contract Win and Corporate Update
8th Feb 20248:42 amRNSStatement re Share Price Movement
5th Feb 20247:00 amRNSCorporate Update
10th Jan 20247:00 amRNSFY23 Update
5th Jan 20247:00 amRNSBoard Change
28th Dec 20232:52 pmRNSTrading Update
1st Dec 20233:31 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSResult of placing of shares in Sondrel (Holdings)
23rd Nov 20237:00 amRNSChange of Nominated Adviser and Broker
13th Nov 20237:00 amRNSProduction Order
20th Oct 20237:00 amRNSFounding member of Arm Total Design ecosystem
27th Sep 202312:01 pmRNSNotification of Major Holdings
27th Sep 202311:57 amRNSNotification of Major Holdings
21st Sep 20237:00 amRNSDelivery of prototypes for three ASIC projects
21st Sep 20237:00 amRNSResults for the half year ended 30 June 2023
20th Sep 20231:09 pmRNSBoard Update
18th Sep 20237:00 amRNSSenior Management Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.